Adverse Drug Event Reporting The Roles of Consumers and Health-Care Professionals: Workshop Summary (2007) / Chapter Skim
Currently Skimming:
A Workshop Agenda
A Workshop Agenda
Pages 53-57
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 53... ...
Food and Drug Administration Richard Platt, MD, MS Harvard Medical School 53
|
From page 54... ...
Food and Drug Administration David Hunt, MD, FACS CMS Quality Improvement Group 11:20 am Discussion 12:15 pm Lunch COMMON EvENTS AND THE MODuLATiON OF THEiR FREquENCy By DRugS Topic 1: It is possible that drugs can modify the frequency of occurrence of a relatively common event. How can these events be detected?
|
From page 55... ...
J Wood, MD Vanderbilt Medical School 3:10 pm Discussion 3:40 pm Break THE ROLE OF PATiENTS AND CONSuMERS iN THE ADvERSE EvENT REPORTiNg SySTEM Topic 1: How should consumers be involved in reporting adverse events?
|
From page 56... ...
9:30 am Discussion Topic 2: Assuming that a database of adverse drug reactions exists (either rare events or common events that occur alone or as a result of drug-drug interactions) , should this information be on a uniform drug label that separates adverse drug events and interactions by severity?
|
From page 57... ...
Food and Drug Administration Ed Staffa, RPh National Association of Chain Drug Stores Cary Sennett, MD, PhD American Board of Internal Medicine 10:40 am Discussion 11:00 am Break Topic 3: Are there electronic systems that can be used to prompt health care providers to look for adverse drug related events and warn against potential drug-drug interactions? How are these systems deployed?
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.